← SynDRA
MK-0557
SynDRA canonical compound SYN0020397 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | NPY5R |
| Mechanism of action | neuropeptide receptor antagonist |
All known targets
Mechanisms of action (all sources)
- NPY5R ANTAGONIST
- Neuropeptide Y receptor type 5 antagonist
- neuropeptide receptor antagonist
Cross-references
Synonyms
Look up MK-0557 in the interactive SynDRA portal →